ANIX
ANIX
NASDAQ · Biotechnology

Anixa Biosciences Inc

$2.81
+0.23 (+8.91%)
As of Apr 1, 3:06 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +440.2% upside
Low Target $12.50
Average Target $15.18
High Target $18.81
Current Price $2.81
Current
$2.81
Target
$15.18
$12.50 $15.18 avg $18.81
Scenario Analysis
Bear Case
$12.50
344.8%
Low target
Base Case
$15.18
+440.2%
Avg target
Bull Case
$18.81
+569.4%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$5.46
-48.5% from high
52-Week Low
$2.33
+20.5% from low
Target vs 52W High
$15.18
+178.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%